{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:26:18Z","timestamp":1792110378028,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.neuro.2012.01.011","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T17:06:13Z","timestamp":1328634373000},"page":"833-837","source":"Crossref","is-referenced-by-count":64,"title":["Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration"],"prefix":"10.1016","volume":"33","author":[{"given":"Anumantha","family":"Kanthasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vellareddy","family":"Anantharam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sondarva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velusamy","family":"Rangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2012.01.011_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nature Reviews"},{"key":"10.1016\/j.neuro.2012.01.011_bib0015","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1523\/JNEUROSCI.22-05-01738.2002","article-title":"Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl","volume":"22","author":"Anantharam","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0020","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0025","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuro.2012.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.neuro.2012.01.011_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","article-title":"Parkinson's disease \u2013 is there a link","volume":"114","author":"Brown","year":"2006","journal-title":"Environmental Health Perspectives"},{"key":"10.1016\/j.neuro.2012.01.011_bib0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1471-4159.2007.05106.x","article-title":"Programmed cell death and new discoveries in the genetics of parkinsonism","volume":"104","author":"Burke","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0050","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuro.2012.01.011_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-6606-2-29","article-title":"The emerging role of autophagy in Parkinson's disease","volume":"2","author":"Cheung","year":"2009","journal-title":"Molecular Brain"},{"key":"10.1016\/j.neuro.2012.01.011_bib0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neuro.2012.01.011_bib0065","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0166-2236(00)01998-6","article-title":"The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders","volume":"24","author":"Chung","year":"2001","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neuro.2012.01.011_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/009841000156907","article-title":"Organochlorine insecticides in substantia nigra in Parkinson's disease","volume":"59","author":"Corrigan","year":"2000","journal-title":"Journal of Toxicology and Environmental Health A"},{"key":"10.1016\/j.neuro.2012.01.011_bib0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1289\/ehp.7570","article-title":"Developmental pesticide models of the Parkinson disease phenotype","volume":"113","author":"Cory-Slechta","year":"2005","journal-title":"Environmental Health Perspectives"},{"key":"10.1016\/j.neuro.2012.01.011_bib0080","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neuro.2006.05.012","article-title":"Paraquat exposure as an etiological factor of Parkinson's disease","volume":"27","author":"Dinis-Oliveira","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ana.410360119","article-title":"Parkinson's disease and brain levels of organochlorine pesticides","volume":"36","author":"Fleming","year":"1994","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0095","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1074\/jbc.C800206200","article-title":"Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system","volume":"284","author":"Inglis","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0100","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1074\/jbc.M110.203687","article-title":"Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death","volume":"286","author":"Jin","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0105","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1523\/JNEUROSCI.5634-10.2011","article-title":"Alpha-synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity","volume":"31","author":"Jin","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0110","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/jm970031d","article-title":"Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives","volume":"40","author":"Kaneko","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1369.022","article-title":"Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death","volume":"1074","author":"Kanthasamy","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.neuro.2012.01.011_bib0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neuro.2004.07.010","article-title":"Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis","volume":"26","author":"Kanthasamy","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-1-12","article-title":"Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson's disease","volume":"1","author":"Kanthasamy","year":"2008","journal-title":"Molecular Brain"},{"key":"10.1016\/j.neuro.2012.01.011_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157015911795017353","article-title":"Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity","volume":"9","author":"Kanthasamy","year":"2011","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0135","doi-asserted-by":"crossref","first-page":"28721","DOI":"10.1074\/jbc.M501092200","article-title":"Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells","volume":"280","author":"Kaul","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0140","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1046\/j.1460-9568.2003.02864.x","article-title":"Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration","volume":"18","author":"Kaul","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0145","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0891-5849(01)00726-2","article-title":"Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells","volume":"31","author":"Kitazawa","year":"2001","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.neuro.2012.01.011_bib0150","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0306-4522(03)00226-4","article-title":"Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration","volume":"119","author":"Kitazawa","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.104.078469","article-title":"Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells","volume":"313","author":"Latchoumycandane","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuro.2012.01.011_bib0165","unstructured":"Lin M, Chandramani Shivalingappa P, Jin H, Anantharam V, Ali S, Kanthasamy AG, et al. Methamphetamine-induced neurotoxicity linked to UPS dysfunction and autophagy related changes that can be modulated by PKC\u03b4 in dopaminergic neuronal cells. Neuroscience, in press."},{"key":"10.1016\/j.neuro.2012.01.011_bib0170","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/mds.22828","article-title":"A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts","volume":"24","author":"Marras","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuro.2012.01.011_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0180","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M109.081950","article-title":"Phosphorylation of synucleins by members of the Polo-like kinase family","volume":"285","author":"Mbefo","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.neuro.2012.01.011_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/syn.20471","article-title":"Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users","volume":"62","author":"McCann","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neuro.2012.01.011_bib0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neuro.2012.01.011_bib0195","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(25)22434-X","article-title":"Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL\/6J mouse","volume":"270","author":"Miller","year":"1994","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2011.05.046","article-title":"Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease","volume":"189","author":"Morrow","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2012.01.011_bib0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jns.2009.02.375","article-title":"Mixed lineage kinase 2 and hippocalcin are localized in Lewy bodies of Parkinson's disease","volume":"281","author":"Nagao","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.neuro.2012.01.011_bib0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004010050687","article-title":"p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease","volume":"94","author":"Nakamura","year":"1997","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.neuro.2012.01.011_bib0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(93)91712-2","article-title":"Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum","volume":"601","author":"Nakayama","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.neuro.2012.01.011_bib0220","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-3565(25)22433-8","article-title":"Neurotoxicity profiles of substituted amphetamines in the C57BL\/6J mouse","volume":"270","author":"O\u2019Callaghan","year":"1994","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nature Medicine"},{"issue":"Suppl. 17","key":"10.1016\/j.neuro.2012.01.011_bib0230","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease \u2013 2007","volume":"22","author":"Olanow","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuro.2012.01.011_bib0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Research"},{"key":"10.1016\/j.neuro.2012.01.011_bib0240","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1096\/fj.06-5864fje","article-title":"Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease","volume":"20","author":"Richardson","year":"2006","journal-title":"FASEB Journal"},{"key":"10.1016\/j.neuro.2012.01.011_bib0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.neuro.2012.01.011_bib0250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuro.2011.06.009","article-title":"Environmental neurotoxic pesticide dieldrin activates a non receptor tyrosine kinase to promote pkcdelta-mediated dopaminergic apoptosis in a dopaminergic neuronal cell model","volume":"32","author":"Saminathan","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/exnr.1997.6770","article-title":"Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures","volume":"150","author":"Sanchez-Ramos","year":"1998","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0265","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/mol.109.062174","article-title":"Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration","volume":"77","author":"Song","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0270","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuro.2011.05.018","article-title":"Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration","volume":"32","author":"Song","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neuro.2012.01.011_bib0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.105.084632","article-title":"Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death","volume":"315","author":"Sun","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0285","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuro.2006.06.006","article-title":"Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models","volume":"27","author":"Sun","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2007.04.001","article-title":"Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease","volume":"114","author":"Sun","year":"2007","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0295","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1582-4934.2008.00293.x","article-title":"Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKCdelta proteolytic activation and mitochondrial translocation","volume":"12","author":"Sun","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.neuro.2012.01.011_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0305","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn1100","article-title":"Targeting programmed cell death in neurodegenerative diseases","volume":"4","author":"Vila","year":"2003","journal-title":"Nature Reviews"},{"key":"10.1016\/j.neuro.2012.01.011_bib0310","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1093\/hmg\/ddi413","article-title":"Stress-induced alterations in parkin solubility promote parkin aggregation and compromise Parkin's protective function","volume":"14","author":"Wang","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.neuro.2012.01.011_bib0315","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pharmtox.44.101802.121840","article-title":"Mixed-lineage kinases: a target for the prevention of neurodegeneration","volume":"44","author":"Wang","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.neuro.2012.01.011_bib0320","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neuro.2012.01.011_bib0325","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson's disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.neuro.2012.01.011_bib0330","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/15287390701459262","article-title":"The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells","volume":"70","author":"Yang","year":"2007","journal-title":"Journal of Toxicology and Environmental Health A"},{"key":"10.1016\/j.neuro.2012.01.011_bib0335","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neuro.2012.01.011_bib0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.20928","article-title":"LRRK2 protein is a component of Lewy bodies","volume":"60","author":"Zhu","year":"2006","journal-title":"Annals of Neurology"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X12000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X12000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T01:12:52Z","timestamp":1742433172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X12000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0161813X12000265"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2012.01.011","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}